HCA Healthcare, Inc. $HCA Stock Holdings Lessened by TD Asset Management Inc

TD Asset Management Inc lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 562,244 shares of the company’s stock after selling 15,374 shares during the period. TD Asset Management Inc owned about 0.25% of HCA Healthcare worth $239,628,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Clearstead Trust LLC grew its position in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. raised its holdings in shares of HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after buying an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC bought a new stake in HCA Healthcare during the 2nd quarter valued at $40,000. Compound Global Advisors LLC bought a new stake in shares of HCA Healthcare during the third quarter valued at about $44,000. Finally, True Wealth Design LLC raised its position in shares of HCA Healthcare by 179.5% during the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after buying an additional 70 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $526.39 on Wednesday. The firm has a fifty day moving average price of $490.31 and a two-hundred day moving average price of $457.88. The firm has a market cap of $117.71 billion, a price-to-earnings ratio of 18.55, a P/E/G ratio of 1.64 and a beta of 1.36. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $552.90.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The firm had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is 10.15%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,214 shares of company stock worth $7,797,595 in the last quarter. 1.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently weighed in on HCA. Barclays upped their price objective on HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a report on Wednesday, January 28th. Wells Fargo & Company lifted their price target on shares of HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a research report on Friday, January 30th. UBS Group raised their price objective on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research note on Monday. Royal Bank Of Canada increased their price target on HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Finally, KeyCorp set a $503.00 target price on shares of HCA Healthcare in a research note on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $532.45.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.